Luteolin inhibits the expression of TLR4 and JNK mRNA in pancreases of T2DM rats, and it improves IR and alleviates pancreatic inflammatory reactions in T2DM rats (22). Here, MAPK8 is linked to type 2 diabetes mellitus.